Cargando…
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation
Autores principales: | Shkoukani, Abdallah, Srinath, Abhinav, Stadnik, Agnieszka, Girard, Romuald, Shenkar, Robert, Sheline, Adrienne, Dahlem, Kristen, Lee, Cornelia, Flemming, Kelly, Awad, Issam A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424017/ https://www.ncbi.nlm.nih.gov/pubmed/34520969 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.106101 |
Ejemplares similares
-
Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation
por: Li, Ying, et al.
Publicado: (2023) -
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma
por: Srinath, Abhinav, et al.
Publicado: (2023) -
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma
por: Polster, Sean P., et al.
Publicado: (2020) -
Developmental venous anomalies are a genetic primer for cerebral
cavernous malformations
por: Snellings, Daniel A., et al.
Publicado: (2022) -
Propranolol as therapy for cerebral cavernous malformations: a cautionary note
por: Shenkar, Robert, et al.
Publicado: (2022)